Stem, Inc. Form 8-K Summary
Business Context and Reporting Period
Stem, Inc. filed a Current Report on Form 8-K dated March 1, 2022, reporting executive compensation actions under Item 5.02(e). The filing is not a quarterly or annual financial report and does not provide operating results for a reporting period.
Compensation and Other Key Metrics
| Executive | Total LTI Award | RSUs | Options | New Annual Base Salary |
|---|---|---|---|---|
| John Carrington, CEO | $2,000,000 | $1,000,000 | $1,000,000 | $550,000 |
| William Bush, CFO | $1,750,000 | $875,000 | $875,000 | $425,000 |
| Larsh Johnson, CTO | $1,250,000 | $625,000 | $625,000 | $375,000 |
- Total disclosed LTI award value was $5.0 million, consisting of $2.5 million of RSUs and $2.5 million of stock options.
- RSUs vest in four equal annual installments, subject to continued employment.
- Options vest in four equal annual installments, subject to continued employment, with exercise prices set at the closing stock price on the grant date.
- RSU share counts were based on the closing stock price on the grant date. Option amounts were determined using adjusted fair value under the Black-Scholes methodology in accordance with ASC Topic 718.
- The awards were granted under the 2021 Equity Incentive Plan.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating-financial metrics.
Material Changes, Outlook, and Risks
The material changes disclosed are the new long-term incentive awards and increases in annual base salaries for the CEO, CFO, and CTO. The filing provides no management guidance, business outlook, contingency disclosures, or discussion of operating risks.
Future expense recognition, dilution, and potential cash tax or settlement effects associated with the awards are not quantified in the filing. Vesting is dependent on continued employment, and the filing does not describe performance conditions.
Investor Verification Items
- Verify the grant date, closing stock price, option exercise prices, and exact share and option counts in the underlying award agreements or subsequent filings.
- Assess the potential dilution from the RSUs and options.
- Review subsequent financial statements for stock-based compensation expense related to these awards.
- Confirm the effective dates and any later changes to the disclosed executive base salaries.